Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 231,119,072 papers from all fields of science
Search
Sign In
Create Free Account
CD 349
Known as:
CD-349
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
Calcium Channel Blockers
Dihydropyridines
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1993
1993
Comparison of a Calcium Antagonist, CD‐349, with Nifedipine, Diltiazem, and Verapamil in Rabbit Spontaneously Beating Sinoatrial Node Cells
H. Satoh
,
K. Tsuchida
Journal of Cardiovascular Pharmacology
1993
Corpus ID: 23597822
Effects of CD-349, a novel 1,4-dihydro-pyridine, and other calcium antagonists on membrane potentials in spontaneously beating…
Expand
1993
1993
Metabolic fate of a new dihydropyridine calcium antagonist, CD-349, in rat and dog.
N. Ogawa
,
K. Mizuno
,
K. Fukushima
,
T. Suwa
,
T. Satoh
Xenobiotica; the fate of foreign compounds in…
1993
Corpus ID: 27440955
1. The metabolic fate of 14C-CD-349, a new calcium antagonist, was studied in rat and dog. 2. After oral administration of 14C…
Expand
1992
1992
Effects of CD-349 and 8-BrcGMP on isoproterenol-induced relaxation in rabbit aorta precontracted with endothelin-1.
N. Miyata
,
H. Yamaura
,
K. Tsuchida
,
S. Otomo
American Journal of Physiology
1992
Corpus ID: 31100086
We investigated the effects of CD-349, a dihydropyridine derivative, on isoproterenol (Iso)-induced relaxation in rabbit aorta…
Expand
1991
1991
Protein Kinase C‐Mediated Contraction in Rabbit Aorta is Inhibited by CD‐349, a Dihydropyridine Derivative
N. Miyata
,
K. Tsuchida
,
S. Otomo
Journal of Cardiovascular Pharmacology
1991
Corpus ID: 35719772
Summary: We investigated the effects of nitroglycerin (NTG), atrial natriuretic peptide (ANP), and CD-349 on phorbol dibutyrate…
Expand
1991
1991
Electrophysiological Effects of CD‐349, a Dihydropyridine‐Type Calcium Antagonist, on Goat Cardiac Purkinje Fibers
K. Tsuchida
,
K. Kaneko
,
H. Aihara
Journal of Cardiovascular Pharmacology
1991
Corpus ID: 28922621
We examined the calcium antagonistic action of CD-349, a dihydropyridine derivative, on goat cardiac Purkinje fibers using the…
Expand
1989
1989
Alteration of cyclic GMP metabolism by CD-349, a novel calcium antagonist, and by sodium nitroprusside in bovine intrapulmonary artery and vein.
Tanaka Makoto
,
Muramatsu Makoto
,
Aihara Hironaka
1989
Corpus ID: 84812170
1988
1988
A new Ca-antagonist, CD-349, binding to the Ca-channel of rat myocardium and brain and hog coronary artery.
M. Muramatsu
,
A. Fujita-Tominaga
,
M. Tanaka
,
Y. Ishii
,
H. Aihara
Japanese Journal of Pharmacology
1988
Corpus ID: 30994279
The binding to a Ca-channel of a novel 1,4-dihydropyridine (DHP) Ca-antagonist, 2-nitratopropyl 3-nitratopropyl 2,6-dimethyl-4-(3…
Expand
1987
1987
Different sensitivities of Ca2+, calmodulin-dependent cyclic nucleotide phosphodiesterases from rabbit aorta and brain to dihydropyridine calcium channel blockers.
S. Matsushima
,
T. Tanaka
,
M. Saitoh
,
M. Watanabe
,
H. Hidaka
Biochemical and Biophysical Research…
1987
Corpus ID: 20189318
1987
1987
Inhibition of adenosine 3',5'-cyclic monophosphate phosphodiesterase by CD-349, a novel 1,4-dihydropyridine derivative: effect of EGTA on the inhibitory activity.
Makoto Tanaka
,
Makoto Muramatsu
,
Hironaka Aihara
Japanese Journal of Pharmacology
1987
Corpus ID: 26128762
CD-349 (2-nitratopropyl 3-nitratopropyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate) inhibited the…
Expand
1987
1987
Effects of the new calcium antagonist 2-nitratopropyl-3-nitratopropyl-2,6-dimethyl-4-(3-nitrophe nyl)- 1,4-dihydropyridine-3,5-dicarboxylate on cerebral circulation in dogs.
K. Tsuchida
,
R. Yamazaki
,
K. Kaneko
,
H. Aihara
Arzneimittel-Forschung
1987
Corpus ID: 22292648
2-Nitratopropyl-3-nitratopropyl-2,6-dimethyl-4-(3-nitropheny l)- 1,4-dihydropyridine-3,5-dicarboxylate (CD-349), nimodipine and…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required